ABL Bio Inc. (KOSDAQ: 298380)
South Korea
· Delayed Price · Currency is KRW 30,550
-950 (-3.02%)
Nov 19, 2024, 9:00 AM KST
62.76% (1Y)
| Market Cap | 1.39T |
| Revenue (ttm) | 32.32B |
| Net Income (ttm) | -88.43B |
| Shares Out | 48.05M |
| EPS (ttm) | -1,846.54 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,406,954 |
| Open | 31,800 |
| Previous Close | 31,500 |
| Day's Range | 30,250 - 32,450 |
| 52-Week Range | 18,730 - 43,300 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |